Suppr超能文献

肾移植患者血浆硫唑嘌呤和6-巯基嘌呤水平的定量分析

Quantitation of plasma azathioprine and 6-mercaptopurine levels in renal transplant patients.

作者信息

Lin S N, Jessup K, Floyd M, Wang T P, van Buren C T, Caprioli R M, Kahan B D

出版信息

Transplantation. 1980 Apr;29(4):290-94. doi: 10.1097/00007890-198004000-00006.

Abstract

The plasma of renal transplant patients was analyzed by high performance liquid chromatography (HPLC) for the presence of azathioprine and its primary metabolite, 6-mercaptopurine, after either oral or i.v. administration of azathioprine. Azathioprine was demonstrated in plasma at peak concentrations of 0.6 microgram/ml 15 min after i.v. injections of 100 to 200 mg. Within 90 min of injection, the azathioprine level fell to 10 ng/ml. Azathioprine was not detected in plasma at any time after an oral dose of 100 mg, indicating that the plasma concentration is less than 0.5 ng/ml, which is the sensitivity limit of this assay. 6-Mercaptopurine appeared in the plasma after either oral or i.v. azathioprine administration. Furthermore, decreased renal graft function has no effect on the rate of disappearance of azathioprine from plasma. These results demonstrate that high performance liquid chromatography can be used to determine azathioprine and 6-mercaptopurine levels in man, and that alteration in renal function does not influence early stages of azathioprine degradation.

摘要

采用高效液相色谱法(HPLC)分析肾移植患者血浆中硫唑嘌呤及其主要代谢产物6-巯基嘌呤的含量,这些患者接受了硫唑嘌呤的口服或静脉注射给药。静脉注射100至200毫克硫唑嘌呤后15分钟,血浆中硫唑嘌呤的峰值浓度为0.6微克/毫升。注射后90分钟内,硫唑嘌呤水平降至10纳克/毫升。口服100毫克后,血浆中任何时候都未检测到硫唑嘌呤,这表明血浆浓度低于0.5纳克/毫升,这是该检测方法的灵敏度极限。口服或静脉注射硫唑嘌呤后,血浆中均出现6-巯基嘌呤。此外,肾移植功能下降对硫唑嘌呤从血浆中消失的速率没有影响。这些结果表明,高效液相色谱法可用于测定人体中硫唑嘌呤和6-巯基嘌呤的水平,并且肾功能的改变不影响硫唑嘌呤降解的早期阶段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验